Clinical trial
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00005042 · AIDS Malignancy Consortium, Other · Completed
Key facts
| NCT number | NCT00005042 |
|---|---|
| Title | SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma |
| Official title | A Multicenter, Open-Label, Phase II Study of SU5416 in Patients With Cutaneous AIDS-Related Kaposi's Sarcoma |
| Lead sponsor | AIDS Malignancy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | semaxanib |
| Start date | Jan 1, 2000 |
| Primary completion | Nov 1, 2000 |
| Completion | Nov 1, 2000 |
| First posted | Jul 19, 2004 |
| Last update posted | Aug 29, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: